cephalosporin c has been researched along with dibekacin in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (47.37) | 18.7374 |
| 1990's | 7 (36.84) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, K; Suzuki, Y; Yokota, N | 1 |
| Niijima, T | 1 |
| Fujita, S; Kumagai, T; Nakanuma, Y; Okuda, K; Takegoshi, K; Tohyama, T | 1 |
| Konishi, H | 1 |
| Goi, H; Hara, T; Kazuno, Y; Matsuhashi, Y; Sugano, T; Tanaka, Y; Watanabe, T; Yamamoto, H; Yokota, T | 1 |
| Van der Auwera, P | 1 |
| Carret, G; Flandrois, JP | 1 |
| Aznar, J; Iglesias, MC; Martin, E; Nogales, MC; Perea, EJ | 1 |
| Azuma, K; Nishino, T; Saito, M; Tanino, T | 1 |
| Hadley, WK; Mills, J; Pulliam, L | 1 |
| Federspil, P | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, K; Suzuki, Y; Yokota, N | 1 |
| Kanno, M; Kawabata, T; Sobu, K; Takase, Y; Watanabe, T; Yoshida, T | 1 |
| Arakawa, K; Kono, K; Takeda, S; Tatara, I | 1 |
| Deguchi, T; Ito, Y; Kanematsu, M; Kawada, Y; Komeda, H; Okano, M; Saitoh, A; Takahashi, Y; Tokuyama, H; Yamada, S | 1 |
| Higurashi, Y; Nakahara, K; Okuzumi, K; Yoneyama, A | 1 |
| Fukuhara, J; Homma, S; Kouda, M; Takeuchi, M; Tamura, K; Udagawa, I | 1 |
| Araake, M; Hara, T; Miyata, A; Ogawa, H; Tani, M | 1 |
| Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H | 1 |
2 review(s) available for cephalosporin c and dibekacin
| Article | Year |
|---|---|
[New antimicrobial agent series XL: arbekacin].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Humans; In Vitro Techniques; Methicillin Resistance; Mice; Staphylococcal Infections; Staphylococcus aureus | 1991 |
Drug-induced sudden hearing loss and vestibular disturbances.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Diuretics; Female; Gentamicins; Guinea Pigs; Hearing Loss, Sudden; Humans; Maternal-Fetal Exchange; Pregnancy; Rats; Tobramycin; Vestibule, Labyrinth | 1981 |
17 other study(ies) available for cephalosporin c and dibekacin
| Article | Year |
|---|---|
[Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. IV. Combined effects of arbekacin with cefmetazole or flomoxef].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefmetazole; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Methicillin Resistance; Staphylococcus aureus | 1992 |
Drug-induced mononucleosis-like hepatic injury in a patient with systemic lupus erythematosus.
Topics: Adult; Cefoxitin; Cephalosporins; Chemical and Drug Induced Liver Injury; Dibekacin; Female; Humans; Indomethacin; Infectious Mononucleosis; Lupus Erythematosus, Systemic | 1989 |
[A case of bronchiolitis obliterans organizing pneumonia in a patient with long-term administration of antibiotics and bone graft].
Topics: Bone Transplantation; Bronchiolitis Obliterans; Cefotaxime; Cephalosporins; Cephapirin; Dibekacin; Drug Therapy, Combination; Humans; Kanamycin; Lung; Male; Middle Aged; Pulmonary Fibrosis; Tibial Fractures | 1988 |
[Antibacterial activities of arbekacin, a new aminoglycoside antibiotic, against methicillin-cephem-resistant Staphylococcus aureus].
Topics: Abscess; Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Dibekacin; Kanamycin; Male; Methicillin; Mice; Penicillin Resistance; Skin Diseases; Staphylococcus aureus | 1987 |
Interaction of gentamicin, dibekacin, netilmicin and amikacin with various penicillins, cephalosporins, minocycline and new fluoro-quinolones against Enterobacteriaceae and Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Interactions; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Penicillins; Pseudomonas aeruginosa; Quinolines | 1985 |
[Nonparametric approach to the determination of critical diameters. Comparison with conventional methods].
Topics: Ampicillin; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Dibekacin; Escherichia coli; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus | 1984 |
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Cefsulodin; Cephalosporins; Dibekacin; Drug Synergism; Gentamicins; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1980 |
[Combination action of sisomicin, dibekacin and cefotetan, cefotaxime, latamoxef, and cefsulodin against Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Cefotaxime; Cefotetan; Cefsulodin; Cephalosporins; Cephamycins; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Escherichia coli; Kanamycin; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Sisomicin | 1983 |
In vitro comparison of third-generation cephalosporins, piperacillin, dibekacin, and other aminoglycosides against aerobic bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cephalosporins; Dibekacin; Kanamycin; Microbial Sensitivity Tests; Penicillins; Piperacillin | 1981 |
[Antibiotic efficacies of combined uses of arbekacin and various antibiotics against methicillin-resistant Staphylococcus aureus].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Therapy, Combination; Fosfomycin; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Staphylococcus aureus | 1994 |
[Basic studies on combination effects of arbekacin and beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Cephalosporins; Cilastatin; Dibekacin; Drug Therapy, Combination; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus | 1994 |
In vitro activities of arbekacin, alone and in combination, against methicillin-resistant Staphylococcus aureus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Ceftizoxime; Cephalosporins; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus | 1994 |
[A study of methicillin-resistant Staphylococcus aureus (MRSA) infection in urological field].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Humans; Immunocompromised Host; Methicillin Resistance; Minocycline; Serotyping; Staphylococcus aureus; Urologic Diseases; Vancomycin | 1993 |
[The in vitro antibacterial activity of cefozopran against clinically isolated bacteria].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefozopran; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Vancomycin | 1997 |
[Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Teicoplanin; Vancomycin | 2000 |
[Combination effect of arbekacin and cefepime on mixed culture of MRSA and P. aeruginosa].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefepime; Cephalosporins; Dibekacin; Drug Synergism; Drug Therapy, Combination; Humans; Methicillin Resistance; Pseudomonas aeruginosa; Staphylococcus aureus; Teicoplanin; Time Factors; Vancomycin | 2001 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin | 2006 |